Extended release venlafaxine formulation
US7470435B2 · kind B2 · utility
2Cited by
27References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 17, 2003 |
| Grant date | Dec 30, 2008 |
| Priority date | — |
| Expiry date | Dec 6, 2025 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/5047
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A controlled release dosage form of venlafaxine that comprises an immediate release pellet and an extended release pellet.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.